(MENAFN- GlobeNewsWire - Nasdaq) Significant market opportunities in the Europe at-home respiratory care services sector include growing demand driven by technological advancements like smart inhalers, increased prevalence of chronic respiratory diseases, telehealth adoption, and a rising elderly population, which collectively enhance personalized patient care and home-based management solutions.

Dublin, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The "Europe At-home Respiratory Care Services Market Size, Share & Trends Analysis Report by Therapy (Oxygen Therapy, Non-Invasive Ventilation), by Indication (Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea), and Segment Forecasts, 2025-2033" report has been added to ResearchAndMarkets's offering.
The Europe at-home respiratory care services market size was estimated at USD 15.24 billion in 2024 and is projected to reach USD 31.15 billion by 2033, growing at a CAGR of 8.42% from 2025 to 2033. Technological advancements in medical devices, such as the development of smart inhalers, connected nebulizers, and integrated mobile applications, have revolutionized traditional methods of respiratory management.

For instance, in February 2024, Aptar Pharma, a global provider of drug delivery systems and active material science solutions, launched HeroTracker Sense, an innovative digital respiratory health solution designed to convert traditional pressurized metered dose inhalers (pMDIs) into smart, connected healthcare devices. This cutting-edge technology enables real-time monitoring and data-driven management of respiratory conditions, enhancing treatment adherence and supporting more personalized patient care.
The rising prevalence of chronic respiratory diseases is driving the growth of at-home respiratory care services across Europe. According to a European Respiratory Society article, approximately 36.6 million people in Europe were living with chronic obstructive pulmonary disease (COPD) in 2020, with projections indicating a rise to 49.45 million by 2050, equivalent to a 9.3% prevalence.
Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea are increasingly affecting the population, requiring long-term and often continuous respiratory support. These chronic respiratory conditions significantly affect patients' daily functioning and contribute to increased pressure on national healthcare systems, particularly through elevated hospital admission rates and greater demands on healthcare resources.
Moreover, a growing elderly demographic across Europe is leading to higher incidences of chronic respiratory diseases, increasing the demand for home-based respiratory care. As per the United Nations Population Division report, the share of population aged 65 and above has significantly increased in recent years in Europe, reaching approximately 19.8% in 2023.
Furthermore, the rapid expansion of telehealth and digital health tools is transforming at-home respiratory care services in Europe. Telehealth enables remote consultations, monitoring, and clinical follow-up via digital platforms, reducing the need for physical hospital visits. During the COVID-19 pandemic, the adoption of telemedicine became integral to managing chronic respiratory patients safely at home. In the UK, the NHS launched large-scale remote monitoring initiatives between 2020 and 2023, supporting over 487,000 people at home, including those with COPD and heart failure. Home-based digital tools increased patients' access improved self-management, and lessened pressure on traditional healthcare facilities.
In addition, empowering patients through education, digital self-management tools, and patient-centered service models is influencing market growth. Initiatives across Europe aim to equip individuals and caregivers with the necessary knowledge and digital resources to effectively manage respiratory conditions at home. For instance, the NHS has invested in tele-coaching, self-care apps, and remote education modules for respiratory patients, which promote adherence and improve disease outcomes.

Why should you buy this report?

• Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
• Competitive Landscape: Explore the market presence of key players.
• Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
• Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Key Attributes:

Report Attribute	Details
No. of Pages	123
Forecast Period	2024 - 2033
Estimated Market Value (USD) in 2024	$15.24 Billion
Forecasted Market Value (USD) by 2033	$31.15 Billion
Compound Annual Growth Rate	8.4%
Regions Covered	Europe

Market Dynamics

Market Driver Analysis

• Increasing prevalence of chronic respiratory diseases and growing aging population
• Rising telehealth and digital health adoption
• Growing patient empowerment and engagement programs

Market Restraint Analysis

• Safety concerns and improper usage in home settings
• Economic pressures and infrastructure gaps

Business Environment Analysis Tools

• Industry Analysis - Porter's Five Forces Analysis
• PESTEL Analysis

Companies Featured

• Linde Healthcare
• Bastide Group
• Vivisol (SOL Group)
• SOS Oxygene
• Air Liquide Healthcare

Europe At-Home Respiratory Care Services Market Report Segmentation
Therapy Outlook (Revenue, USD Billion, 2021-2033)

• Oxygen therapy
• Non-invasive ventilation
• Sleep apnea care
• Aerosol therapy and others

Indication Outlook (Revenue, USD Billion, 2021-2033)

• Chronic Obstructive Pulmonary Disease (COPD)
• Sleep apnea (obstructive and central types)
• Asthma
• Post-acute respiratory failure

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• European At-home Respiratory Care Services Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN02102025004107003653ID1110142432